Mar 07, 2023 / 08:25PM GMT
Jayson Tyler Bedford - Raymond James & Associates, Inc., Research Division - MD & Senior Medical Supplies and Devices Analyst
All right. Good afternoon. I think we'll get started. Thank you, and welcome to the 44th Annual Raymond James Institutional Investors Conference. I think there's a couple of seats up front if you guys are looking. But my name is Jayson Bedford. I cover the medical technology sector. And it's really our pleasure to have with us Dexcom who's been a loyal participant at this conference for many, many years, even when the market cap was much, much smaller. So congrats on all the success.
With that, we have the company's CFO, Jereme Sylvain. So with that, I'll pass it off.
Jereme M. Sylvain - DexCom, Inc. - Executive VP, CFO & CAO
Thank you, Jayson. Appreciate it. Thanks to everybody that come out and spend a little time with us today. We'll cover a little bit about the background of the organization, just where we're going -- where we've been, where we're going and a few different angles as to where the organization you
Dexcom Inc at Raymond James Institutional Investors Conference Transcript
Jan 22, 2024
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers